LENSAR, Inc.
LENSAR, Inc. (LNSR) Financial Performance & Income Statement Overview
Explore the financials of LENSAR, Inc. (LNSR), including yearly and quarterly data on income, cash flow, and balance sheets.
LENSAR, Inc. (LNSR) Income Statement & Financial Overview
Access detailed annual and quarterly income data for LENSAR, Inc. LNSR financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $14.16M | $16.73M | $13.54M | $12.64M |
| Cost of Revenue | $7.03M | $9.62M | $7.27M | $6.05M |
| Gross Profit | $7.13M | $7.11M | $6.27M | $6.58M |
| Gross Profit Ratio | $0.50 | $0.42 | $0.46 | $0.52 |
| R&D Expenses | $1.53M | $1.33M | $1.20M | $1.35M |
| SG&A Expenses | $11.15M | $6.83M | $6.08M | $6.78M |
| Operating Expenses | $12.68M | $8.40M | $7.28M | $8.13M |
| Total Costs & Expenses | $19.72M | $17.28M | $14.55M | $14.19M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $1.11M | $1.006M | $898000.00 |
| EBITDA | -$5.56M | -$184000.00 | -$239000.00 | -$653000.00 |
| EBITDA Ratio | -$0.39 | -$0.01 | -$0.02 | -$0.05 |
| Operating Income | -$5.56M | -$1.29M | -$1.01M | -$1.55M |
| Operating Income Ratio | -$0.39 | -$0.08 | -$0.07 | -$0.12 |
| Other Income/Expenses (Net) | -$21.79M | -$17.41M | -$489000.00 | -$7.49M |
| Income Before Tax | -$27.34M | -$18.70M | -$1.50M | -$9.04M |
| Income Before Tax Ratio | -$1.93 | -$1.12 | -$0.11 | -$0.72 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$27.34M | -$18.70M | -$1.50M | -$9.04M |
| Net Income Ratio | -$1.93 | -$1.12 | -$0.11 | -$0.72 |
| EPS | -$2.32 | -$1.61 | -$0.13 | -$0.79 |
| Diluted EPS | -$2.32 | -$1.61 | -$0.13 | -$0.79 |
| Weighted Avg Shares Outstanding | $11.77M | $11.63M | $11.60M | $11.45M |
| Weighted Avg Shares Outstanding (Diluted) | $11.77M | $11.63M | $11.60M | $11.45M |
Financial performance has remained strong, with revenue growing from $12.64M in Q2 2024 to $14.16M in Q1 2025. Gross profit continued to perform well, with margins at 50% in the latest quarter. Operating income reached -$5.56M in Q1 2025, holding a steady -39% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$5.56M. Net income dropped to -$27.34M, keeping EPS at -$2.32. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan